RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Jodie Fleming to Humans

This is a "connection" page, showing publications Jodie Fleming has written about Humans.
Connection Strength

0.242
  1. Barrow MA, Martin ME, Coffey A, Andrews PL, Jones GS, Reaves DK, Parker JS, Troester MA, Fleming JM. A functional role for the cancer disparity-linked genes, CRY?B2 and CRY?B2P1, in the promotion of breast cancer. Breast Cancer Res. 2019 09 11; 21(1):105.
    View in: PubMed
    Score: 0.033
  2. Martin ME, Reaves DK, Jeffcoat B, Enders JR, Costantini LM, Yeyeodu ST, Botta D, Kavanagh TJ, Fleming JM. Silver nanoparticles alter epithelial basement membrane integrity, cell adhesion molecule expression, and TGF-?1 secretion. Nanomedicine. 2019 10; 21:102070.
    View in: PubMed
    Score: 0.032
  3. Fleming JM, Yeyeodu ST, McLaughlin A, Schuman D, Taylor DK. In Situ Drug Delivery to Breast Cancer-Associated Extracellular Matrix. ACS Chem Biol. 2018 10 19; 13(10):2825-2840.
    View in: PubMed
    Score: 0.031
  4. Reaves DK, Hoadley KA, Fagan-Solis KD, Jima DD, Bereman M, Thorpe L, Hicks J, McDonald D, Troester MA, Perou CM, Fleming JM. Nuclear Localized LSR: A Novel Regulator of Breast Cancer Behavior and Tumorigenesis. Mol Cancer Res. 2017 02; 15(2):165-178.
    View in: PubMed
    Score: 0.027
  5. Reaves DK, Ginsburg E, Bang JJ, Fleming JM. Persistent organic pollutants and obesity: are they potential mechanisms for breast cancer promotion? Endocr Relat Cancer. 2015 Apr; 22(2):R69-86.
    View in: PubMed
    Score: 0.024
  6. Reaves DK, Fagan-Solis KD, Dunphy K, Oliver SD, Scott DW, Fleming JM. The role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior. PLoS One. 2014; 9(3):e91747.
    View in: PubMed
    Score: 0.022
  7. Fleming JM, Ginsburg E, McAndrew CW, Heger CD, Cheston L, Rodriguez-Canales J, Vonderhaar BK, Goldsmith P. Characterization of ?7/11, a functional prolactin-binding protein. J Mol Endocrinol. 2013 Feb; 50(1):79-90.
    View in: PubMed
    Score: 0.021
  8. Fleming JM, Miller TC, Kidacki M, Ginsburg E, Stuelten CH, Stewart DA, Troester MA, Vonderhaar BK. Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo. Breast Cancer Res. 2012 Jun 25; 14(3):R97.
    View in: PubMed
    Score: 0.020
  9. Fleming JM, Ginsburg E, Oliver SD, Goldsmith P, Vonderhaar BK. Hornerin, an S100 family protein, is functional in breast cells and aberrantly expressed in breast cancer. BMC Cancer. 2012 Jun 22; 12:266.
    View in: PubMed
    Score: 0.020
  10. Oladapo HO, Tarpley M, Sauer SJ, Addo KA, Ingram SM, Strepay D, Ehe BK, Chdid L, Trinkler M, Roques JR, Darr DB, Fleming JM, Devi GR, Williams KP. Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in?vivo tumor growth of inflammatory breast cancer cells. Cancer Lett. 2017 12 28; 411:136-149.
    View in: PubMed
    Score: 0.007
  11. D'Arcy M, Fleming J, Robinson WR, Kirk EL, Perou CM, Troester MA. Race-associated biological differences among Luminal A breast tumors. Breast Cancer Res Treat. 2015 Jul; 152(2):437-48.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support